BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Brunetto MR, Colombatto P, Bonino F. Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis. World J Gastroenterol 2009; 15(5): 531-537 [PMID: 19195054 DOI: 10.3748/wjg.15.531]
URL: https://www.wjgnet.com/1007-9327/full/v15/i5/531.htm
Number Citing Articles
1
Q. Zheng, Y. Y. Zhu, J. Chen, Y. R. Liu, J. You, J. Dong, D. W. Zeng, L. Y. Gao, L. H. Chen, J. J. Jiang. Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg lossJournal of Viral Hepatitis 2014; 21(12): 909 doi: 10.1111/jvh.12261
2
Barbara Locke, Eva Forsgren, Ingemar Fries, Joachim R. de Miranda. Acaricide Treatment Affects Viral Dynamics in Varroa destructor-Infested Honey Bee Colonies via both Host Physiology and Mite ControlApplied and Environmental Microbiology 2012; 78(1): 227 doi: 10.1128/AEM.06094-11
3
Dong Jin Suh, Soon Ho Um, Eva Herrmann, Ju-Hyun Kim, Young Sok Lee, Heon Ju Lee, Myung Seok Lee, Youn-Jae Lee, Weibin Bao, Patricia Lopez, Han Chu Lee, Claudio Avila, Stefan Zeuzem. Early Viral Kinetics of Telbivudine and Entecavir: Results of a 12-Week Randomized Exploratory Study with Patients with HBeAg-Positive Chronic Hepatitis BAntimicrobial Agents and Chemotherapy 2010; 54(3): 1242 doi: 10.1128/AAC.01163-09
4
Daniel Shouval. FocusJournal of Hepatology 2013; 58(4): 641 doi: 10.1016/j.jhep.2013.01.008
5
Jörg Petersen, Maria Buti. Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogsExpert Review of Gastroenterology & Hepatology 2012; 6(6): 683 doi: 10.1586/egh.12.52
6
Joachim R de Miranda, Lesley Bailey, Brenda V Ball, Philippe Blanchard, Giles E Budge, Nor Chejanovsky, Yan-Ping Chen, Laurent Gauthier, Elke Genersch, Dirk C de Graaf, Magali Ribière, Eugene Ryabov, Lina De Smet, Jozef J M van der Steen. Standard methods for virus research inApis melliferaJournal of Apicultural Research 2013; 52(4): 1 doi: 10.3896/IBRA.1.52.4.22
7
Christian W W Pirk, Joachim R de Miranda, Matthew Kramer, Tomàs E Murray, Francesco Nazzi, Dave Shutler, Jozef J M van der Steen, Coby van Dooremalen. Statistical guidelines forApis melliferaresearchJournal of Apicultural Research 2013; 52(4): 1 doi: 10.3896/IBRA.1.52.4.13
8
Thomas A. O’Shea-Wheller, Frank D. Rinkevich, Robert G. Danka, Michael Simone-Finstrom, Philip G. Tokarz, Kristen B. Healy. A derived honey bee stock confers resistance to Varroa destructor and associated viral transmissionScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-08643-w
9
E Ahmed, HA El-Saka. On multi-strain model for Hepatitis CNonlinear Biomedical Physics 2011; 5(1) doi: 10.1186/1753-4631-5-6
10
Marco Montagnani, Marina Giandinoto, Andrea Lisotti, Silvia Galli, Francesco Azzaroli, Federica Buonfiglioli, Laura Turco, Rita Aldini, Giuseppe Mazzella. High Dose Lamivudine in HBV-Related Cirrhotic Patients with Unsatisfactory Response After Adefovir Add-OnDigestive Diseases and Sciences 2012; 57(2): 561 doi: 10.1007/s10620-011-1873-x
11
Clara Balsano, Patrizia Burra, Christophe Duvoux, Anna Alisi, Fabio Piscaglia, Alessio Gerussi, Maurizia Rossana Brunetto, Ferruccio Bonino, Roberto Montalti, Silvia Campanile, Marcello Persico, Domenico Alvaro, Silvano Santini, Pietro Invernizzi, Marco Carbone, Mario Masarone, Albino Eccher, Bruno Siciliano, Mario Vento, Fanny Ficuciello, Federico Cabitza, Simone Penasa, Piergiorgio Donatelli. Artificial Intelligence and liver: Opportunities and barriersDigestive and Liver Disease 2023; 55(11): 1455 doi: 10.1016/j.dld.2023.08.048
12
Harel Dahari, Jeremie Guedj, Alan S. Perelson, Thomas J. Layden. Hepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and Interleukin-28BCurrent Hepatitis Reports 2011; 10(3): 214 doi: 10.1007/s11901-011-0101-7
13
Nancy W. Y. Leung, Eva Herrmann, George K. K. Lau, Henry L. Y. Chan, Tokutei M. K. So, Stefan Zeuzem, Yu Dong, Aldo Trylesinski, Nikolai V. Naoumov. Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BInfectious Diseases and Therapy 2014; 3(2): 191 doi: 10.1007/s40121-014-0039-5
14
Bruno C. de Sousa, Celso Cunha, Andrew Yates. Development of Mathematical Models for the Analysis of Hepatitis Delta Virus Viral DynamicsPLoS ONE 2010; 5(9): e12512 doi: 10.1371/journal.pone.0012512
15
T. Bader. Does fluvastatin favour HCV replicationin vivo? A pilot study on HIV-HCV co-infected patientsJournal of Viral Hepatitis 2010; 17(3): 227 doi: 10.1111/j.1365-2893.2009.01185.x
16
P. Colombatto, M. R. Brunetto, A. M. Maina, V. Romagnoli, P. Almasio, M. G. Rumi, A. Ascione, G. Pinzello, M. Mondelli, L. Muratori, R. Rappuoli, D. Rosa, M. Houghton, S. Abrignani, F. Bonino. HCV E1E2‐MF59 vaccine in chronic hepatitis C patients treated with PEG‐IFNα2a and Ribavirin: a randomized controlled trialJournal of Viral Hepatitis 2014; 21(7): 458 doi: 10.1111/jvh.12163
17
E Ahmed, H A El-Saka. On fractional order models for Hepatitis CNonlinear Biomedical Physics 2010; 4(1) doi: 10.1186/1753-4631-4-1